Back to BARCLAYS PLC BARCLAYS PLC

KPTIKPTI
6 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in KARYOPHARM THERAPEUTICS INC

BARCLAYS PLC holds 165,904 shares of KPTI (KARYOPHARM THERAPEUTICS INC), worth $1.6M as of 2026-Q2. The position was increased (+2134.7% shares). KPTI represents 0.0% of BARCLAYS PLC's portfolio.

Current Value

$1.6M

Current Shares

165,904

Total Value Change

+$1.6M

Total Shares Change

+160,571

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
165,904
+2134.7%
$1.6M0.0%$9.77
41
2026-Q1
Increased
7,424
+80.7%
$41,3520.0%$9.13
21
2025-Q4
Unchanged
4,109
0.0%
$30,2420.0%$7.31
0
2025-Q3
Decreased
4,109
-22.9%
$26,8730.0%$6.35
0
2025-Q2
Unchanged
5,333
0.0%
$22,9850.0%$4.39
0
2025-Q1
New
5,333
-
$19,9450.0%$4.16
29

Other major holders of KPTI: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., GOLDMAN SACHS GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used